P19ARF and RasV12 offer opposing regulation of DHX33 translation to dictate tumor cell fate

Yandong Zhang, Anthony J. Saporita, Jason D. Weber

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

DHX33 is a pivotal DEAH-box RNA helicase in the multistep process of RNA polymerase I-directed transcription of the ribosomal DNA locus. We explored the regulation of DHX33 expression by RasV12 and ARF to determine DHX33's role in sensing these opposing signals to regulate ribosome biogenesis. In wild-type primary fibroblasts, RasV12 infection induced a transient increase in DHX33 protein level, as well as an rRNA transcriptional rate that was eventually suppressed by a delayed activation of the ARF/p53 pathway. DHX33 expression was exclusively controlled at the level of translation. ARF caused a dramatic reduction in polysome-associated DHX33 mRNAs, while RasV12 led to a complete shift of existing DHX33 mRNAs to actively translating polysomes. The translation of DHX33 by RasV12 was sensitive to inhibitors of phosphatidylinositol 3-kinase, mTOR, and mitogen-activated protein and was pivotal for enhanced rRNA transcription and enhanced overall cellular protein translation. In addition, DHX33 knockdown abolished RasV12-induced rRNA transcription and protein translation and prevented both the in vitro and in vivo transforming properties of oncogenic RasV12. Our results directly implicate DHX33 as a crucial player in establishing rRNA synthesis rates in the face of RasV12 or ARF signals, adjusting ribosome biogenesis to match the appropriate growth or antigrowth signals.

Original languageEnglish
Pages (from-to)1594-1607
Number of pages14
JournalMolecular and cellular biology
Volume33
Issue number8
DOIs
StatePublished - Apr 2013

Fingerprint Dive into the research topics of 'P19<sup>ARF</sup> and Ras<sup>V12</sup> offer opposing regulation of DHX33 translation to dictate tumor cell fate'. Together they form a unique fingerprint.

  • Cite this